Centogene: FDA Issues Emergency Use Authorization For SARS-CoV-2 RT-PCR Assay

(RTTNews) - Centogene N.V. (CNTG) said the FDA has issued Emergency Use Authorization for CentoSure, the company's SARS-CoV-2 RT-PCR test. CentoSure SARS-CoV-2 RT-PCR assay is a real-time test based on the reverse transcription polymerase chain reaction for the qualitative detection of SARS-CoV-2, the virus causing COVID-19.

Arndt Rolfs, CEO of CENTOGENE, said, "This emergency use authorization by the FDA is an extremely important further step to prevent a further spread of COVID-19, specifically in countries that have been heavily impacted, like the U.S.".

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

In This Story


Latest Markets Videos


Founded in the late 1990s by Andrew Mariathasan in New York, with the goal of covering Wall Street for a new generation of investors, RTTNews has expanded steadily over the years to become a trusted provider of content for a wide array of subjects across several platforms. RTT's Financial Newswire is relied upon by some of the world's largest financial institutions, including banks, brokerages, trading platforms and financial exchanges.

Learn More